30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United Kingdom Healthcare Equipment & Supplies

Creo Medical Group PLC (CREO)

Track

Over the last 90 days, Creo Medical Group PLC has seen 5 insider buy transactions totaling £250,000. Notably, the CEO, Group Finance Director, and Non-Executive Chairman were among those purchasing shares. There were no insider sell transactions during this period. The stock has seen an 11.3% price increase over the past 90 days.
Stock chart
Ticker: CREO Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Peter Tracey
Non-Executive Chairman
1 purchase — total 100,000 GBP
Buy 23 Jun 2026
Value £508,174.63 | Price 121.56 | Shares 21,664
Buy 23 Jun 2026
Value £4,678,402.68 | Price 214.25 | Shares 35,487
Buy 23 Jun 2026
Value £100,000.00 | Price 0.50 | Shares 1,000
Buy 23 Jun 2026
Value £100,000.00 | Price 0.50 | Shares 1,000
Buy 23 Jun 2026
Value £100,000.00 | Price 0.50 | Shares 1,000
Buy 13 Dec 2024
Value £200,606.85 | Price 0.17 | Shares 1,179,000
Buy 24 Oct 2024
Value £15,359.51 | Price 0.20 | Shares 76,740
Through Richard Rees, a closely affiliated person
Buy 24 Oct 2024
Value £19,614.70 | Price 0.20 | Shares 98,000
Sale 24 Oct 2024
Value £34,948.00 | Price 0.20 | Shares 174,740
Buy 21 Oct 2024
Value £49,999.92 | Price 0.24 | Shares 208,333
Buy 21 Oct 2024
Value £699,999.84 | Price 0.24 | Shares 2,916,666
Buy 9 Mar 2023
Value £888,497.00 | Price 0.20 | Shares 4,442,485
Buy 9 Mar 2023
Value £25,000.00 | Price 0.20 | Shares 125,000
Buy 9 Mar 2023
Value £253,027.00 | Price 0.20 | Shares 1,265,135
Buy 9 Mar 2023
Value £83,051.00 | Price 0.20 | Shares 415,255
Buy 9 Mar 2023
Value £76,634.20 | Price 0.20 | Shares 383,171
Buy 9 Mar 2023
Value £543,064.40 | Price 0.20 | Shares 2,715,322
Buy 9 Mar 2023
Value £200,000.00 | Price 0.20 | Shares 1,000,000
Through Kathryn Hogg, a closely affiliated person
Buy 9 Mar 2023
Value £33,023.80 | Price 0.20 | Shares 165,119
Buy 26 May 2022
Value £67,725.00 | Price 0.97 | Shares 70,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-23 2026-06-23 B Purchase Peter Tracey

Non-Executive Chairman

Director
21,664
121.56
£508,175 		21,664 121.56 £508,175
2026-06-23 2026-06-23 B Purchase
Michael Scheepers

Chief Executive Officer

Officer
35,487
214.25
£4,678,403 		35,487 214.25 £4,678,403
2026-06-23 2026-06-23 B Purchase
3.0
Jonathan Hill

Group Finance Director

Executive Director
86,805
167.11
£2,446,854 		86,805 167.11 £2,446,854
2026-06-23 2026-06-23 B Purchase
2.8
Jeremy Wilson

Non-Executive Director

Executive Director
1,000
0.50
£100,000 		1,000 0.50 £100,000
2026-06-23 2026-06-23 B Purchase Angela Luger

Senior Non-Executive Director

Executive Director
1,000
0.50
£100,000 		1,000 0.50 £100,000
2024-12-16 2024-12-13 B Purchase
Kevin T. Crofton

Non-Executive Chairman

Director
1,179,000
0.17
£200,607 		1,179,000 0.17 £200,607
2024-10-24 2024-10-24 B Purchase
Rachel Rees

CFO

Through Richard Rees, a closely affiliated person Officer
76,740
0.20
£15,360 		76,740 0.20 £15,360
2024-10-24 2024-10-24 B Purchase
Richard Rees

Chief Financial Officer

Officer
98,000
0.20
£19,615 		98,000 0.20 £19,615
2024-10-24 2024-10-24 S Sale
Richard Rees

Chief Financial Officer

Officer
174,740
0.20
£34,948 		174,740 0.20 £34,948
2024-10-21 2024-10-21 B Purchase
Richard Rees

Chief Financial Officer

Officer
208,333
0.24
£50,000 		208,333 0.24 £50,000
2024-10-21 2024-10-21 B Purchase
Kevin Crofton

Non-Executive Chairman

Director
2,916,666
0.24
£700,000 		2,916,666 0.24 £700,000
2023-03-13 2023-03-09 B Purchase
Luis Collantes

PDMR
4,442,485
0.20
£888,497 		4,442,485 0.20 £888,497
2023-03-13 2023-03-09 B Purchase
1.7
Ivonne Cantu

Independent Non-Executive Director

Non-Executive Director
125,000
0.20
£25,000 		125,000 0.20 £25,000
2023-03-13 2023-03-09 B Purchase
John Bradshaw

Independent Non-Executive Director

Non-Executive Director
1,265,135
0.20
£253,027 		1,265,135 0.20 £253,027
2023-03-13 2023-03-09 B Purchase
2.5
David Woods

Chief Commercial Officer

Officer
415,255
0.20
£83,051 		415,255 0.20 £83,051
2023-03-13 2023-03-09 B Purchase
1.9
Professor Christopher Hancock

Chief Technology Officer

Officer
383,171
0.20
£76,634 		383,171 0.20 £76,634
2023-03-13 2023-03-09 B Purchase
Richard Rees

Chief Financial Officer

Officer
2,715,322
0.20
£543,064 		2,715,322 0.20 £543,064
2023-03-13 2023-03-09 B Purchase
Craig Gulliford

Chief Executive Officer

Through Kathryn Hogg, a closely affiliated person Officer
1,000,000
0.20
£200,000 		1,000,000 0.20 £200,000
2023-03-13 2023-03-09 B Purchase
2.2
Charles Spicer

Non-Executive Chairman

Director
165,119
0.20
£33,024 		165,119 0.20 £33,024
2022-05-27 2022-05-26 B Purchase
Richard Rees

Chief Financial Officer

Officer
70,000
0.97
£67,725 		70,000 0.97 £67,725
Explore more

More insider trading research around Creo Medical Group PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in Europe